1. Keeping Pace with Pharmaceutical Innovation: The Importance of the NICE Methods Review

   • Paul Catchpole
   • Victoria Barrett

   Commentary Open access 24 April 2020 Pages: 901 - 903

2. Financing Drug Innovation in the US: Current Framework and Emerging Challenges

   • David Cutler
   • Noam Kirson
   • Genia Long

   Current Opinion 26 May 2020 Pages: 905 - 911

3. Health State Utility Values in Juvenile Idiopathic Arthritis: What is the Evidence?

   • Luiza Raquel Grazziotin
   • Gillian Currie
   • Deborah A. Marshall

   Systematic Review 11 May 2020 Pages: 913 - 926

   

4. Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review

   • T. Joseph Mattingly II
   • Bryan L. Love
   • Bilal Khokhar

   Systematic Review Open access 12 June 2020 Pages: 927 - 939

   

5. Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States

   • Sang Kyu Cho
   • Beenish S. Manzoor
   • Scott Johnson

   Original Research Article Open access 08 May 2020 Pages: 941 - 951

   

6. Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM

   • Michael Willis
   • Adam Fridhammar
   • Pierre Johansen

   Original Research Article Open access 13 May 2020 Pages: 953 - 969

   

7. Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis

   • Jesse Elliott
   • Bláthnaid McCoy
   • Doug Coyle

   Original Research Article 14 May 2020 Pages: 971 - 980

   

8. Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria

   • Thomas O’Connell
   • Marric Buessing
   • Ioannis Tomazos

   Original Research Article Open access 10 June 2020 Pages: 981 - 994

   

9. Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates

   • Allison Portnoy
   • Kelsey Vaughan
   • Nicolas A. Menzies

   Original Research Article Open access 28 June 2020 Pages: 995 - 1005

   

10. Inclisiran as Adjunct Lipid-Lowering Therapy for Patients with Cardiovascular Disease: A Cost-Effectiveness Analysis

    • Ning Kam
    • Kanila Perera
    • Zanfina Ademi

    Original Research Article 13 August 2020 Pages: 1007 - 1020